Methyl N-(cis)-1-benzyl-4-methylpiperidin-3-yl]-carbamate hydrochloride

Request For Quotation
Methyl N-(cis)-1-benzyl-4-methylpiperidin-3-yl]-carbamate hydrochloride Suppliers list
Company Name: Guangzhou Zhenlin Pharmaceutical Technology Co., Ltd  
Tel: 020-18102736 13622807357
Email: Zark@zlstandards.com
Company Name: Hubei Rhema Reference Materials Technology Co., Ltd.  
Tel: 15787879035 15787875101
Email: ydw9035@rmastandards.com
Methyl N-(cis)-1-benzyl-4-methylpiperidin-3-yl]-carbamate hydrochloride Basic information
Product Name:Methyl N-(cis)-1-benzyl-4-methylpiperidin-3-yl]-carbamate hydrochloride
Synonyms:Methyl N-(cis)-1-benzyl-4-methylpiperidin-3-yl]-carbamate hydrochloride;rel-N-[(3R,4R)-4-Methyl-1-(phenylmethyl)-3-piperidinyl]carbamic acid methyl ester;methyl N-(1-benzyl-4-methylpiperidin-3-yl)carbamate;Carbamic acid, N-[(3R,4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-, methyl ester, rel-;Tofacitinib Impurity 40 HCl;Tofacitinib Impurity 43 HCl
CAS:694495-65-3
MF:C15H22N2O2
MW:262.35
EINECS:
Product Categories:
Mol File:694495-65-3.mol
Methyl N-(cis)-1-benzyl-4-methylpiperidin-3-yl]-carbamate hydrochloride Structure
Methyl N-(cis)-1-benzyl-4-methylpiperidin-3-yl]-carbamate hydrochloride Chemical Properties
Boiling point 376.987±31.00 °C(Press: 760.00 Torr)(predicted)
density 1.104±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted)
pka12.072±0.40(predicted)
Safety Information
HazardClass IRRITANT
MSDS Information
Methyl N-(cis)-1-benzyl-4-methylpiperidin-3-yl]-carbamate hydrochloride Usage And Synthesis
Methyl N-(cis)-1-benzyl-4-methylpiperidin-3-yl]-carbamate hydrochloride Preparation Products And Raw materials
Tag:Methyl N-(cis)-1-benzyl-4-methylpiperidin-3-yl]-carbamate hydrochloride(694495-65-3) Related Product Information
3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile 2,4-Dichloro-7-tosyl-7H-pyrrolo[2,3-d]pyriMidine 4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine Ethanone, 2-methoxy-1-[(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]- N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine Tofacitinib Impurity 85 butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate 4-Amino-2,6-dichloropyrimidine 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 3-[(3S,4S)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile methyl ((3R,4R)-4-methylpiperidin-3-yl)carbamate hydrochloride N-(1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine 2-Chloro-3,7-dihydro-4H-pyrrolo[2,3-d]pyriMidin-4-one 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 2-chloro-N-methyl-7-[(4-methylphenyl)sulfonyl]-N-[(3R,4R)-4-methyl-3-piperidinyl]- Tofacitinib Impurity 29 Tofacitinib Impurity 2 (1-Benzyl-4-Methyl-1,2,5,6-tetrahydropyridin-3-yl)carbaMic acid Methyl ester